CN105530929B - 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途 - Google Patents

3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途 Download PDF

Info

Publication number
CN105530929B
CN105530929B CN201480050485.3A CN201480050485A CN105530929B CN 105530929 B CN105530929 B CN 105530929B CN 201480050485 A CN201480050485 A CN 201480050485A CN 105530929 B CN105530929 B CN 105530929B
Authority
CN
China
Prior art keywords
carboxy
ethyl
ammonium
dimethylpropan
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480050485.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN105530929A (zh
Inventor
马尧伊·达姆布罗瓦
海伦娜·奇鲁尔
伊瓦尔斯·卡尔温斯
埃德加斯·利平斯
叶琳娜·马卡罗娃
伊尔马斯·斯托南斯
伊尔加·米萨内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grindeks A Jsc
Original Assignee
Grindeks A Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks A Jsc filed Critical Grindeks A Jsc
Publication of CN105530929A publication Critical patent/CN105530929A/zh
Application granted granted Critical
Publication of CN105530929B publication Critical patent/CN105530929B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480050485.3A 2013-09-26 2014-09-15 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途 Active CN105530929B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13186201.3 2013-09-26
EP13186201 2013-09-26
PCT/IB2014/064514 WO2015044828A1 (fr) 2013-09-26 2014-09-15 Utilisation de 3-carboxy-n-éthyl-n,n-diméthylpropan-1-aminium ou d'un sel pharmaceutiquement acceptable de celui-ci dans la prévention et le traitement du diabète

Publications (2)

Publication Number Publication Date
CN105530929A CN105530929A (zh) 2016-04-27
CN105530929B true CN105530929B (zh) 2018-03-02

Family

ID=49231372

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480050485.3A Active CN105530929B (zh) 2013-09-26 2014-09-15 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途

Country Status (9)

Country Link
CN (1) CN105530929B (fr)
AR (1) AR099638A1 (fr)
BR (1) BR112016004211B1 (fr)
CA (1) CA2924682C (fr)
JO (1) JO3333B1 (fr)
MX (1) MX368505B (fr)
TN (1) TN2016000064A1 (fr)
WO (1) WO2015044828A1 (fr)
ZA (1) ZA201600894B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067474A1 (fr) * 2007-12-05 2009-06-10 Grindeks, a joint stock company Nouvelle utilisation médicale de sel propionate 3-(2,2,2-trimethylhydrazinium)
LV14345B (lv) * 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
SI2702033T1 (sl) 2011-04-27 2016-09-30 Grindeks, A Joint Stock Company Uporaba soli 3-karboksi-n-etil-n,n-dimteilpropan-1-amina pri zdravljenju bolezni srca in ožilja

Also Published As

Publication number Publication date
ZA201600894B (en) 2017-05-31
CA2924682A1 (fr) 2015-04-02
BR112016004211A2 (fr) 2017-08-01
CN105530929A (zh) 2016-04-27
WO2015044828A1 (fr) 2015-04-02
CA2924682C (fr) 2018-02-27
BR112016004211B1 (pt) 2022-09-06
TN2016000064A1 (en) 2017-07-05
JO3333B1 (ar) 2019-03-13
MX2016003347A (es) 2016-06-24
MX368505B (es) 2019-10-04
AR099638A1 (es) 2016-08-10

Similar Documents

Publication Publication Date Title
JP6889231B2 (ja) レボドパ、ドーパミン脱炭酸酵素阻害薬およびｃｏｍｔ阻害薬を含む医薬組成物ならびにその投与方法
US20260102334A1 (en) Dopa decarboxylase inhibitor compositions
US20250073193A1 (en) Dopa decarboxylase inhibitor compositions
JP6401317B2 (ja) がんを治療するためのシステム、方法、および製剤
EP4295909A2 (fr) Promédicaments de carbidopa et de l-dopa et méthodes d'utilisation
JP2025015727A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤
JP2025011312A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
EP3432874B1 (fr) Méthodes et compositions pour le traitement du syndrome de prader-willi
JP2021519272A5 (fr)
KR20250043584A (ko) 신경퇴행성 장애의 치료를 위한 약제학적 조성물의 연속 투여
CA2924682C (fr) Utilisation de 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium ou d'un sel pharmaceutiquement acceptable de celui-ci dans la prevention et le traitement du diabete
RU2467748C1 (ru) Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью
CN100402029C (zh) 包含埃坡霉素衍生物和烷化剂的组合
US7026338B2 (en) Pharmaceutical nitrones
RU2467744C1 (ru) Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2465268C1 (ru) Производное 3-(2,2,2-триметилгидразиний)пропионата - никотинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью
RU2467745C1 (ru) Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
US20090111893A1 (en) Method of lowering blood glucose and method of preventing or treating blood glucose and method of preventing or treating diabetes and obesity
WO2021108923A1 (fr) Utilisation combinée de trans-[tétrachloridobis (1h-indazole)ruthénate de sodium (iii)] et d'etomoxir pour le traitement de cancers
HK40043418B (en) Dopa decarboxylase inhibitor compositions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant